Cafepharma Today

September 18 2024 - FDA scraps adcomm for Applied's rare disease drug ahead of November decision
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
Ascendis trial data piles pressure on BioMarin
Agency warns J&J over 340B rebate plan
GSK touts co-administration data for RSV, shingles vaccines
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Nektar completes $115M asset sale to Novartis
Bizjournals.com
Friday, January 2, 2009 - 10:45am
tags:
Nektar, Novartis
Equivocal Data on Plavix Flummox FDA, Doctors
WSJ Online
Friday, January 2, 2009 - 10:44am
tags:
Plavix, Bristol-Myers Squibb
Wyeth Pressured by Generics
Yahoo/Zacks.com
Tuesday, December 30, 2008 - 11:26am
tags:
Wyeth, generics
China Biopharma Takes No Holiday Break
Seeking Alpha
Tuesday, December 30, 2008 - 9:47am
tags:
China
Mylan's Matrix Unit Receives Final FDA Nod for Generic Version of Antiretroviral Zerit Capsules
RTT News
Tuesday, December 30, 2008 - 9:39am
tags:
Mylan, Stavudine
Too Much Optimism for Gilead Sciences?
Seeking Alpha
Tuesday, December 30, 2008 - 9:38am
tags:
Gilead Sciences
Pharma Stocks Buck the Market Trend
Seeking Alpha
Tuesday, December 30, 2008 - 9:37am
tags:
Vertex Pharmaceuticals, Schering Plough, Merck
Drugmakers See Healthy Profits on Flu Pandemic Watch
Seeking Alpha
Tuesday, December 30, 2008 - 8:45am
tags:
Flu, GSK
Schering-Plough Risks Linger
Yahoo/Zacks.com
Tuesday, December 30, 2008 - 8:43am
tags:
Schering Plough
FDA approves new prostate cancer drug
Yahoo/AP
Tuesday, December 30, 2008 - 8:41am
tags:
Ferring, prostate cancer, degarelix
King Completes Acquisition of Alpharma
Yahoo
Tuesday, December 30, 2008 - 8:38am
tags:
King, buyouts, Alpharma
FTC says King will sell painkiller to Actavis to resolve antitrust issue in Alpharma deal
Yahoo/AP
Tuesday, December 30, 2008 - 8:37am
tags:
Kadian, King, Alpharma, Actavis
Fla. to receive $8.5M in settlement with Cephalon
Bizjournals.com
Monday, December 29, 2008 - 12:49pm
tags:
Cephalon
Mylan Generics Fairly Traded
Zacks.com
Monday, December 29, 2008 - 12:47pm
tags:
Mylan
[video]Weak Dollar, Strong Biotech
TheStreet.com
Monday, December 29, 2008 - 10:27am
tags:
biotech, Celgene, Gilead Sciences, Amgen
Pfizer Has Many Opportunities
Yahoo/Zacks.com
Monday, December 29, 2008 - 10:25am
tags:
Pfizer
Are Merck's Dog Days Over?
CNBC
Monday, December 29, 2008 - 10:22am
tags:
Merck
Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements
Yahoo
Monday, December 29, 2008 - 10:21am
tags:
Celera, Abbott Laboratories
[video]Top 2009 Biotech Stocks
TheStreet.com
Monday, December 29, 2008 - 10:19am
tags:
biotech, GSK, Bristol-Myers Squibb, Genentech, Gilead Sciences, Celgene, Amag Pharmaceuticals
Two Calculated Risks Possibly Worth Taking
Seeking Alpha
Monday, December 29, 2008 - 10:17am
tags:
Cypress Bioscience

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information